- Home
- CRDF vs EMX Comparison
CRDF vs EMX Comparison
Compare CRDF & EMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- EMX
- Stock Information
- Founded
- CRDF 1999
- EMX N/A
- Country
- CRDF United States
- EMX Canada
- Employees
- CRDF N/A
- EMX N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- EMX
- Sector
- CRDF Health Care
- EMX
- Exchange
- CRDF Nasdaq
- EMX Nasdaq
- Market Cap
- CRDF 240.2M
- EMX 196.2M
- IPO Year
- CRDF N/A
- EMX N/A
- Fundamental
- Price
- CRDF $3.45
- EMX $1.70
- Analyst Decision
- CRDF Strong Buy
- EMX Strong Buy
- Analyst Count
- CRDF 3
- EMX 1
- Target Price
- CRDF $10.33
- EMX $7.00
- AVG Volume (30 Days)
- CRDF 1.4M
- EMX 287.5K
- Earning Date
- CRDF 02-27-2025
- EMX 11-07-2024
- Dividend Yield
- CRDF N/A
- EMX N/A
- EPS Growth
- CRDF N/A
- EMX N/A
- EPS
- CRDF N/A
- EMX N/A
- Revenue
- CRDF $688,000.00
- EMX $26,818,000.00
- Revenue This Year
- CRDF $25.03
- EMX N/A
- Revenue Next Year
- CRDF N/A
- EMX $2.34
- P/E Ratio
- CRDF N/A
- EMX N/A
- Revenue Growth
- CRDF 49.57
- EMX 25.53
- 52 Week Low
- CRDF $1.44
- EMX $1.41
- 52 Week High
- CRDF $6.42
- EMX $2.15
- Technical
- Relative Strength Index (RSI)
- CRDF 45.05
- EMX 46.20
- Support Level
- CRDF $3.33
- EMX $1.69
- Resistance Level
- CRDF $4.89
- EMX $1.74
- Average True Range (ATR)
- CRDF 0.31
- EMX 0.04
- MACD
- CRDF -0.15
- EMX -0.00
- Stochastic Oscillator
- CRDF 10.56
- EMX 21.43
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").
About EMX EMX Royalty Corporation (Canada)
EMX Royalty Corp and its subsidiaries operate as a royalty and prospect generator engaged in exploring for and generating royalties from, metals and minerals properties. The company is a precious, and base metals royalty company. The Company augments royalty generation with royalty acquisitions and strategic investments. EMX's royalty and mineral property portfolio consists of properties in North America, Europe, Turkiye, Latin America, Morocco, and Australia.